-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on Incyte, Lowers Price Target to $94

Benzinga·03/25/2026 16:03:18
Listen to the news
UBS analyst Ashwani Verma maintains Incyte (NASDAQ:INCY) with a Neutral and lowers the price target from $104 to $94.